GU Hospital participates in nation-wide breast cancer clinical trial

The Lombardi Comprehensive Cancer Center, a part of the Georgetown University Hospital, is taking part in a cutting-edge clinical trial of personalized breast cancer treatment. The treatment program, known as I-SPY 2 (“Investigation of Serial Studies to Predict… Read More

GU Hospital botches breast cancer tests, closes lab

According to the Washington Post, Georgetown University Hospital suspended work in its molecular diagnostics laboratory after two women were incorrectly told that they did not have an aggressive form of breast cancer known as HER2. The lab’s temporary… Read More